Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: A descriptive study of the patients and their characteristics

Scandinavian Journal of Rheumatology

Volumn 44, Issue 2, 2015, Pages 135-142

  Kvarnstrom M ^a   Ottosson, V ^a   Nordmark, B ^a   Wahren Herlenius, M ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY;

ADULT; ARTHRALGIA; ARTICLE; ATROPHIC GASTRITIS; AUTOIMMUNE HEPATITIS; COMORBIDITY; CONTROLLED STUDY; CYTOPENIA; DEPRESSION; DESCRIPTIVE RESEARCH; FATIGUE; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; INTERSTITIAL LUNG DISEASE; LYMPHADENOPATHY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MINOR SALIVA GLAND; MYALGIA; PATIENT REFERRAL; POLYNEUROPATHY; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME; SMOKING; VASCULITIS; AGED; BIOPSY; BLOOD; COMPLICATION; IMMUNOLOGY; LONGITUDINAL STUDY; LUNG DISEASES; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PATHOLOGY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SALIVARY GLAND; SJOGREN'S SYNDROME; SWEDEN;

ADULT; AGED; AUTOANTIBODIES; BIOPSY; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LUNG DISEASES; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SALIVARY GLANDS; SJOGREN'S SYNDROME; SWEDEN;

EID: 84924428174     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2014.931457     Document Type: Article

References (33)

1. Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004;33:39-43.
2. Goransson LG, Haldorsen K, Brun JG, Harboe E, Jonsson MV, Skarstein K, et al. The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scand J Rheumatol 2011;40:221-4.
3. Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, et al. Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area. Arthritis Care Res (Hoboken) 2014;66:454-63.
4. Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ 3rd, O'Fallon WM, et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 2001;76:593-9.
5. Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulou AI, Siozos C, Drosos AA. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006; 45:187-91.
6. Plesivcnik Novljan M, Rozman B, Hocevar A, Grmek M, Kveder T, Tomsic M. Incidence of primary Sjögren's syndrome in Slovenia. Ann Rheum Dis 2004;63:874-6.
7. Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (Hoboken) 2013;65:244-50.
8. Wahren-Herlenius M, Dorner T. Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 2013;382:819-31.
9. Nordmark G, Wang C, Vasaitis L, Eriksson P, Theander E, Kvarnstrom M, et al. Association of genes in the NF-kappaB pathway with antibody positive primary Sjögren's syndrome. Scand J Immunol 2013;78:447-54.
10. Nordmark G, Kristjansdottir G, Theander E, Appel S, Eriksson P, Vasaitis L, et al. Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes Immun 2011;12:100-9.
11. Reksten TR, Johnsen SJ, Jonsson MV, Omdal R, Brun JG, Theander E, et al. Genetic associations to germinal centre formation in primary Sjögren's syndrome. Ann Rheum Dis 2014;73:1253-8.
12. Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nat Genet 2013;45:1284-92.
13. Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjögren's syndrome: novel aspects on pathogenesis. Immunol Lett 2011;141:1-9.
14. Halse A, Tengner P, Wahren-Herlenius M, Haga H, Jonsson R. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome. Scand J Immunol 1999;49:533-8.
15. Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, et al. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum 2003;48:3187-201.
16. Salomonsson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M. Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren's syndrome. Scand J Immunol 2002;55:336-42.
17. Tengner P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 1998;41:2238-48.
18. Espinosa A, Hennig J, Ambrosi A, Anandapadmanaban M, Abelius MS, Sheng Y, et al. Anti-Ro52 autoantibodies from patients with Sjögren's syndrome inhibit the Ro52 E3 ligase activity by blocking the E3/E2 interface. J Biol Chem 2011;286:36478-91.
19. Kvarnstrom M, Dzikaite-Ottosson V, Ottosson L, Gustafsson J, Gunnarsson I, Svenungsson E, et al. Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus. Lupus 2013;22:477-85.
20. Salomonsson S, Sonesson SE, Ottosson L, Muhallab S, Olsson T, Sunnerhagen M, et al. Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block. J Exp Med 2005;201:11-17.
21. Ambrosi A, Dzikaite V, Park J, Strandberg L, Kuchroo VK, Herlenius E, et al. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model. Ann Rheum Dis 2012;71:448-54.
22. Cervera R, Font J, Ramos-Casals M, Garcia-Carrasco M, Rosas J, Morla RM, et al. Primary Sjögren's syndrome in men: clinical and immunological characteristics. Lupus 2000;9:61-4.
23. Garcia-Carrasco M, Cervera R, Rosas J, Ramos-Casals M, Morla RM, Siso A, et al. Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics. Lupus 1999;8:20-3.
24. Ramos-Casals M, Cervera R, Font J, Garcia-Carrasco M, Espinosa G, Reino S, et al. Young onset of primary Sjögren's syndrome: clinical and immunological characteristics. Lupus 1998;7:202-6.
25. Ramirez M, Ramos-Casals M, Graus F. [Central nervous system involvement in primary Sjögren syndrome], in Spanish. Med Clin (Barc) 2009;133:349-59.
26. Botsios C, Furlan A, Ostuni P, Sfriso P, Andretta M, Ometto F, et al. Elderly onset of primary Sjögren's syndrome: clinical manifestations, serological features and oral/ocular diagnostic tests. Comparison with adult and young onset of the disease in a cohort of 336 Italian patients. Joint Bone Spine 2011;78:171-4.
27. Friedman JA, Miller EB, Green L, Huszar M, Schattner A. A community-based cohort of 201 consecutive patients with primary Sjögren's syndrome in Israel: Ashkenazi patients compared with those of Sephardic descent. Clin Exp Rheumatol 2006;24:274-80.
28. Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, et al. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry. Arthritis Care Res (Hoboken) 2012;64:911-18.
29. Ter Borg EJ, Risselada AP, Kelder JC. Relation of systemic autoantibodies to the number of extraglandular manifestations in primary Sjögren's syndrome: a retrospective analysis of 65 patients in the Netherlands. Semin Arthritis Rheum 2011;40:547-51.
30. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
31. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010;69:1103-9.
32. Lindgren B. Analysis of categorical data. In: Statistical theory, 3rd edn. New York: MacMillan Publishing Co. Inc., 1976:423-52.
33. Priori R, Medda E, Conti F, Cassara EA, Sabbadini MG, Antonioli CM, et al. Risk factors for Sjögren's syndrome: a case-control study. Clin Exp Rheumatol 2007;25:378-84.